Prenatal cell-free DNA (cfDNA) screening of chromosome abnormalities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) and the College of American Pathologists (CAP)
Publication date: January 2027 Source: Genetics in Medicine, Volume 29, Issue 1 Author(s): Benjamin A. Hilton, Sucheta Bhatt, Phillip Cacheris, Sung-Hae L. Kang, Edward M. Kloza, Brynn Levy, Ross Rowsey, Bryce A. Seifert, Erin Wakeling, Shashirekha Shetty, ACMG Laboratory Quality Assurance Committee
Prenatal cell-free DNA (cfDNA) screening of chromosome abnormalities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) and the College of American Pathologists (CAP). // Genetics in Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1098360026010610?dgcid=rss_sd_all
Prenatal cell-free DNA (cfDNA) screening of chromosome abnormalities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) and the College of American Pathologists (CAP). Genetics in Medicine. https://www.sciencedirect.com/science/article/pii/S1098360026010610?dgcid=rss_sd_all
“Prenatal cell-free DNA (cfDNA) screening of chromosome abnormalities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) and the College of American Pathologists (CAP).” Genetics in Medicine.
@article{article46708,
title = {Prenatal cell-free DNA (cfDNA) screening of chromosome abnormalities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) and the College of American Pathologists (CAP)},
journal = {Genetics in Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1098360026010610?dgcid=rss_sd_all}
}
ABSTRACT Very long‐chain acyl‐CoA dehydrogenase deficiency (VLCADD) is an autosomal recessive disorder of mitochondrial fatty acid β ‐oxidation caused by biallelic pathogenic variants in ACADVL. Its most severe form, the cardiomyopathic...